Science China Life Sciences

2.5k papers and 44.5k indexed citations i.

About

The 2.5k papers published in Science China Life Sciences in the last decades have received a total of 44.5k indexed citations. Papers published in Science China Life Sciences usually cover Molecular Biology (1.2k papers), Plant Science (405 papers) and Genetics (275 papers) specifically the topics of CRISPR and Genetic Engineering (159 papers), RNA modifications and cancer (122 papers) and Plant Molecular Biology Research (107 papers). The most active scholars publishing in Science China Life Sciences are Jian‐Fang Gui, Shaojun Liu, Dao Wen Wang, George F. Gao and Yulong Yin.

In The Last Decade

Fields of papers published in Science China Life Sciences

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Science China Life Sciences. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Science China Life Sciences

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Science China Life Sciences. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Science China Life Sciences with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025